Model‐Based Comparison of Dose‐Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). The aim of this analysis was to characterize the relationship between tofacitinib dose and efficacy, as measured by American College of Rheumatology (ACR) response rates, and to compare this between Japanes...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Misaki, Shoji, Satoshi, Miyoshi, So, Krishnaswami, Sriram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Pharmacodynamics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972659/
https://www.ncbi.nlm.nih.gov/pubmed/31512746
http://dx.doi.org/10.1002/jcph.1514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972659/
https://www.ncbi.nlm.nih.gov/pubmed/31512746
http://dx.doi.org/10.1002/jcph.1514

Ejemplares similares